Skip to main content
Home

Search form

  • Home
  • Calendar
  • People
    • Key Personnel
    • Members
    • Collaborators
  • Grants
  • Papers
  • Blogs
  • Wiki
  • Log In
Home / In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.

In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.

TitleIn vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Publication TypeJournal Article
Year of Publication2013
AuthorsSotirchos ES, Saidha S, Byraiah G, Mealy MA, Ibrahim MA, Sepah YJamal, Newsome SD, Ratchford JN, Frohman EM, Balcer LJ, Crainiceanu CM, Nguyen QDong, Levy M, Calabresi PA
JournalNeurology
Volume80
Issue15
Pagination1406-14
Date Published2013 Apr 9
ISSN1526-632X
KeywordsAdolescent, Adult, Aged, Aquaporin 4, Autoantibodies, Case-Control Studies, Chi-Square Distribution, Female, Humans, Macular Edema, Male, Middle Aged, Nerve Fibers, Neuromyelitis Optica, Retina, Tomography, Optical Coherence, Vision Tests, Visual Acuity, Young Adult
Abstract

OBJECTIVE: To assess eyes with neuromyelitis optica (NMO) for morphologic retinal abnormalities utilizing high-definition optical coherence tomography (OCT) imaging.

METHODS: In this cross-sectional study, 39 patients with NMO spectrum disorders and 39 age- and sex-matched healthy controls underwent spectral-domain OCT and visual function testing.

RESULTS: Microcystic macular edema (MME) of the inner nuclear layer (INL) was identified in 10 of 39 patients (26%) and was exclusively found in eyes with a history of optic neuritis (ON). MME eyes had lower high- and low-contrast letter-acuity scores (100%: p = 0.002; 2.5%: p = 0.002; 1.25%: p = 0.004), lower peripapillary retinal nerve fiber layer (RNFL) thickness (p = 0.04), lower macular RNFL thickness (p = 0.004), lower ganglion cell layer + inner plexiform layer (GCIP) thickness (p = 0.007), higher INL thickness (p < 0.001), and a greater number of ON episodes (p = 0.008) relative to non-MME eyes with a history of ON. After adjusting for history of multiple ON episodes, these findings remained significant for macular-RNFL thickness (p = 0.03), INL thickness (p < 0.001), and 100% and 2.5% contrast letter-acuity scores (p = 0.008 and p = 0.03, respectively). NMO spectrum eyes without ON history had lower macular RNFL thickness (p = 0.003), GCIP thickness (p = 0.002), outer nuclear layer thickness (p = 0.02), and low-contrast letter-acuity scores (2.5%: p = 0.03; 1.25%: p = 0.002) compared to healthy controls.

CONCLUSIONS: We have identified a pattern of retinal morphologic abnormalities in NMO that is associated with severe retinal axonal and neuronal loss and corresponding visual disability. MME may contribute to poor visual outcomes following NMO-associated ON or alternatively represent a marker of ON severity. Additionally, our results support that subclinical involvement of the anterior visual pathway may occur in NMO spectrum disorders.

DOI10.1212/WNL.0b013e31828c2f7a
Alternate JournalNeurology
PubMed ID23516321
PubMed Central IDPMC3662269
Grant ListR01 EY 014993 / EY / NEI NIH HHS / United States
R01 EY 019473 / EY / NEI NIH HHS / United States
  • Google Scholar
  • BibTeX

Navigation

  • Statistical methods
    • General
    • Causal Inference
    • Population ICA
    • PVD
    • Testing
    • Prediction / Machine Learning
    • Computation
    • Visualization
    • Structural PCA
  • Scientific areas of interest
    • Brain imaging - Variability
    • Brain Imaging - Prediction
    • Brain Imaging - Clinical
    • Wearable Computing
    • Biosignals
  • Software & Tutorials
  • Social media
  • Logos
© 2012 smart-stats.org